Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease

Circulation Journal

Volumn 76, Issue 4, 2012, Pages 950-956

  Virani, Salim S ^a,b   Brautbar, Ariel ^b   Lee, Vei Vei ^c   Elayda, MacArthur ^c   Morrison, Alanna C ^d   Grove, Megan L ^d   Nambi, Vijay ^b   Frazier, Lorraine ^d   Wilson, James M ^c   Willerson, James T ^c   Boerwinkle, Eric ^d   Ballantyne, Christie M ^b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

9p21 locus; Mortality; Recurrent myocardial infarction; Recurrent revascularization

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHROMOSOME 9P; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE FREQUENCY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RECURRENT DISEASE; REVASCULARIZATION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TEXAS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858981200     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1166     Document Type: Article

References (17)

1. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488-1491.
2. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491-1493.
3. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, et al. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet 2009; 2: 279-285.
4. Schunkert H, Götz A, Braund P, McGinnis R, Tregouet DA, Mangino M, et al; Cardiogenics Consortium. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 2008; 117: 1675-1684.
5. Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, Hingorani AD, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008; 54: 467-474.
6. Tsai PC, Liao YC, Lin TH, Hsi E, Yang YH, Juo SHH. Additive Effect of ANRIL and BRAP polymorphisms on ankle-brachial index in a Taiwanese population. Circ J 2012; 76: 446-452.
7. Horne BD, Carlquist JF, Muhlestein JB, Bair TL, Anderson JL. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circ Cardiovasc Genet 2008; 1: 85-92.
8. Dandona S, Stewart AF, Chen L, Williams K, So D, O'Brien E, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol 2010; 56: 479-486.
9. Hoppmann P, Erl A, Türk S, Tiroch K, Mehilli J, Schömig A, et al. No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. JACC Cardiovasc Interv 2009; 2: 1149-1155.
10. Buysschaert I, Carruthers KF, Dunbar DR, Peuteman G, Rietzschel E, Belmans A, et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: The GRACE Genetics Study. Eur Heart J 2010; 31: 1132-1141.
11. Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V, et al. Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol 2011; 107: 1504-1509.
12. Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, et al. Isolated coronary artery bypass grafting in obese individuals: A propensity matched analysis of outcomes. Circ J 2011; 75: 1378-1385.
13. Shen GQ, Li L, Rao S, Abdullah KG, Ban JM, Lee BS, et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 2008; 28: 360-365.
14. Hiura Y, Fukushima Y, Yuno M, Sawamura H, Kokubo Y, Okamura T, et al. Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population. Circ J 2008; 72: 1213-1217.
15. Anderson JL, Horne BD, Kolek MJ, Muhlestein JB, Mower CP, Park JJ, et al. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J 2008; 156: 1155-1162.
16. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
17. Yamagata K, Kataoka Y, Kokubu N, Kasahara Y, Abe M, Nakajima H, et al. A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease. Circ J 2010; 74: 671-678.